Latest Breaking News On - Heron therapeutics inc - Page 3 : comparemela.com

Heron Therapeutics (NASDAQ:HRTX) Reaches New 12-Month High at $3 36

Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX – Get Free Report) reached a new 52-week high during trading on Monday . The stock traded as high as $3.36 and last traded at $3.34, with a volume of 1813390 shares changing hands. The stock had previously closed at $3.20. Analyst Upgrades and Downgrades Several research firms have […]

Victory capital management incSusquehanna fundamental investmentsHeron therapeutics incNeedham companyHeadlands technologiesHeron therapeuticsGet free reportOne financialFundamental investmentsCapital managementHeron therapeutics daily

Heron Therapeutics, Inc (NASDAQ:HRTX) Expected to Post FY2026 Earnings of $0 20 Per Share

Heron Therapeutics, Inc (NASDAQ:HRTX) Expected to Post FY2026 Earnings of $0 20 Per Share
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Heron therapeutics incVictory capital management incSusquehanna fundamental investmentsNeedham companyCommonwealth equity servicesHeadlands technologiesPricet rowe associates incHeron therapeutics company profileHeron therapeuticsFree reportCapital one financialOne financialHeron therapeuticGet free reportCapital managementEquity services

Heron Therapeutics (NASDAQ:HRTX) Receives Buy Rating from Needham & Company LLC

Heron Therapeutics (NASDAQ:HRTX – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at Needham & Company LLC in a report issued on Thursday, Benzinga reports. They presently have a $5.00 price objective on the biotechnology company’s stock. Needham & Company LLC’s price target would suggest a potential upside of 66.67% from the […]

Jw asset managementTejara capital ltdOrchard capital managementHeron therapeutics incNeedham companyHeron therapeuticsGet free reportCapital one financialCapital managementAsset managementCapital ltdHeron therapeutics daily

Antiemetic Drug Market size is set to grow by USD 1632 81 mn from 2023-2027, rising geriatric population globally to boost the market growth, Technavio

Antiemetic Drug Market size is set to grow by USD 1632 81 mn from 2023-2027, rising geriatric population globally to boost the market growth, Technavio
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomUnited statesJesse maidaOndansetron zofranLupin ltdOtsuka holdings coViatris incPfizer incAlgen healthcare ltdWalgreens boots allianceEagle pharmaceuticals incRite aidHeron therapeutics incResearch analysisCipla ltd

Heron Therapeutics, Inc (NASDAQ:HRTX) Expected to Earn Q2 2024 Earnings of ($0 04) Per Share

Heron Therapeutics, Inc (NASDAQ:HRTX) Expected to Earn Q2 2024 Earnings of ($0 04) Per Share
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesNorthland capmkSusquehanna fundamental investmentsCommonwealth equity servicesHeron therapeutics incNeedham companyBoard of administration florida retirement systemHeadlands technologiesVictory capital management incHeron therapeuticsFree reportHeron therapeuticGet free reportOne financialTherapeutics trading downCapital management